KBI Biopharma Capacity Update January 2025: Large Molecule Development
KBI Biopharma is committed to helping customers overcome complex biomanufacturing challenges by leveraging innovations in automation and process development digitization. In this presentation, Derek Ryan, Senior Director of Analytical Development, will showcase how our high-throughput technologies and digital tools enhance process understanding and optimize decision-making.
With a focus on recombinant protein therapeutics and cutting-edge analytical solutions, we deliver actionable insights that accelerate development timelines. Join us to discover how KBI Biopharma’s expertise and advanced capabilities ensure reliable, efficient processes, enabling customers to bring life-changing therapies to patients faster.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.